Why are tumour blood vessels abnormal and why is it important to know?
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Tumour blood vessels differ from their normal counterparts for reasons that have received little attention. We report here that they are of at least six distinct types, we describe how each forms, and, looking forward, encourage the targeting of tumour vessel subsets that have lost their vascular endothelial growth factor-A (VEGF-A) dependency and so are likely unresponsive to anti-VEGF-A therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Although many in vitro microvessel models have been developed, none of them can actually reproduce the architecture of capillaries seen in a tumor [217,218].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [217]
Experimental — accuracy not yet measuredIn the citing paper
“The vasculature of tumors is very different from the blood vessels that supply healthy tissues, especially in terms of heterogeneity, permeability, multidirectional blood flow, and unordered distribution throughout the tumor160.”
From Tumor-on-a-chip: from bioinspired design to biomedical application (2021) · cites this paper as [160]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187 · cited 1×
“Furthermore, recent successes with agents that block VEGF-A or its receptors have supported Folkman’s (1971) thesis that anti-angiogenesis can be a useful supplement to traditional tumour therapy.”
BackgroundTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“As was noted more than 20 years ago, tumour angiogenesis shares many analogies with wound healing (Dvorak, 1986).”
BackgroundSelf-citationTransplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
Hellström, M., Phng, L.-K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., Alva, J., Nilsson, A.-K., Karlsson, L., Gaiano, N., et al. (2007) · Nature · doi:10.1038/nature05571 · Cited by 1,775 · cited 1×
“…of endothelial cells: non-dividing ‘tip’ cells at the leading edge that extend filopodia and sprouts in response to VEGF-A gradients and ‘stalk’ cells that follow behind, divide and exhibit reduced filopodia and sprouting because of signalling through the Notch/delta 4 axis (Hellstrom et al, 2007).”
BackgroundBergers, G., Song, S., Meyer-Morse, N., Bergsland, E., & Hanahan, D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17929 · Cited by 1,370 · cited 1×
“…that anti-VEGF/VEGFR approaches have effectively treated mouse tumours at early stages of their development, but have proved to be less successful in treating established mouse tumours that contain large numbers of more mature, smooth muscle-cell-coated blood vessels (Bergers et al, 2003).”
BackgroundBergers, G., Song, S., Meyer-Morse, N., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317929 · Cited by 1,192
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
Jain, R. K., Duda, D. G., Clark, J. W., & Loeffler, J. S. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0403 · Cited by 1,039 · cited 2×
“Agents that neutralise VEGF (e.g., Avastin, VEGF-TRAP) or its receptors have provided proof of principle that anti-angiogenesis can be a useful adjunct to tumour therapy (Jain et al, 2006).”
BackgroundRuhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H., Betsholtz, C., & Shima, D. T. (2002) · Genes & Development · doi:10.1101/gad.242002 · Cited by 914 · cited 2×
“Mice engineered to express only VEGF-A120 develop to term but generate a capillary network with larger-sized vessels and fewer branch points (Ruhrberg et al, 2002).”
BackgroundLee, S., Jilani, S. M., Nikolova, G. V., Carpizo, D., & Iruela-Arispe, M. L. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200409115 · Cited by 703 · cited 2×
“Similar large, MV-like vessels can be generated by still smaller VEGF-As that result from matrix metalloprotease cleavage (Lee et al, 2005).”
BackgroundVasculogenic Mimicry and Tumor Angiogenesis
Folberg, R., Hendrix, M. J. C., & Maniotis, A. J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64739-6 · Cited by 684 · cited 1×
“…and DV result, respectively, from arteriogenesis and venogenesis. aIn addition, red blood-cell-filled spaces lined by tumour cells rather than by vascular endothelium have been described in some tumours, particularly ocular melanomas, and are referred to as ‘vascular mimicry’ (Folberg et al, 2000).”
Background
Cited by
Items 401–500 of 612
Burns, J. S., Safwat, A., Grisendi, G., Kassem, M. S., & Dominici, M. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.05.027 · Cited by 9
“distribution, permeability and structure, influenced by relatively high concentrations of vascular endothelial growth factor (VEGFA) [54].”
BackgroundApplying Tools From Evolutionary Biology to Cancer Research
Enríquez‐Navas, P. M., & Gatenby, R. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804310-3.00014-4 · Cited by 10
Immune consequences of anti-angiogenic therapy in renal cell carcinoma
Brodaczewska, K. K., Szczylik, C. A., & Kiéda, C. (2018) · Współczesna Onkologia · doi:10.5114/wo.2018.73878 · Cited by 8
“ating a unique, cancer-promoting microenvironment [18].”
Morel, K. L., Ormsby, R. J., Solly, E. L., Tran, L., Sweeney, C. J., Klebe, S., Cordes, N., & Sykes, P. J. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9915-9 · Cited by 7
Trumbull, D. A., Lemini, R., Bagaria, S. P., Elli, E. F., Colibaseanu, D., Wallace, M. B., & Gabriel, E. M. (2020) · JMIR Research Protocols · doi:10.2196/15677 · Cited by 7
Nanophysics in modern medicine
Lozovski, V. Z., Лысенко, В. С., & Rusinchuk, N. (2022) · Semiconductor Physics Quantum Electronics & Optoelectronics · doi:10.15407/spqeo25.02.185 · Cited by 7
Sung, K., Kurowski, A., Lansiquot, C., Wan, K. K., Patnaik, S., Walsh, M. J., & Lazarus, M. B. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00710 · Cited by 7
Hu, S., Lan, X., Zheng, J., Bi, Y., Ye, Y., Si, M., Fang, Y., Wang, J., Liu, J., Chen, Y., et al. (2023) · Physics in Medicine and Biology · doi:10.1088/1361-6560/acf112 · Cited by 7
Spin‐lock imaging of intrinsic susceptibility gradients in tumors
Zu, Z., Janve, V. A., & Gore, J. C. (2019) · Magnetic Resonance in Medicine · doi:10.1002/mrm.28155 · Cited by 7
de Oliveira, E. A., Goding, C. R., & Maria–Engler, S. S. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_369 · Cited by 9
Nawrot, K. C., Zaręba, J. K., Toporkiewicz, M., Chodaczek, G., Wawrzyńczyk, D., Kulbacka, J., Bazylińska, U., & Nyk, M. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s298300 · Cited by 7
“This factor may have important implications for cancer diagnosis and treatment, because large NCs would not enter healthy tissues, but are more likely to diffuse into highly permeable tumour cells.(20) Thus, in our invitrostudies, two human cell lines have been selected, ie, human gingival fibroblasts (HGF) and human…”
BackgroundNano-fenretinide demonstrates remarkable activity in acute promyeloid leukemia cells
Farruggia, G., Anconelli, L., Galassi, L., Voltattorni, M., Rossi, M., Lodeserto, P., Blasi, P., & Orienti, I. (2024) · Scientific Reports · doi:10.1038/s41598-024-64629-w · Cited by 7
“The role of nanoencapsulation in improving on-target activity of antitumor drugs has been widely demonstrated in solid tumors where leaking blood capillaries and inefficient lymphatic drainage promote accumulation and retention of intravenously injected drug-loaded nanoparticles 52–55 .”
BackgroundCOUP-TFII-mediated reprogramming of the vascular endothelium counteracts tumor immune evasion
Zhu, Y., Brulois, K., Dinh, T. T., Pan, J., & Butcher, E. C. (2025) · Nature Communications · doi:10.1038/s41467-025-62399-1 · Cited by 10
de Bock, E. J. E., Stoelinga, B., van Waesberghe, J. H. T. M., Kandi, F. I., Fernandes, C. D., Mischi, M., Huirne, J. A. F., Burger, N. B., & Juffermans, L. J. M. (2025) · WFUMB Ultrasound Open · doi:10.1016/j.wfumbo.2025.100095 · Cited by 7
Bai, Y., You, Y., Chen, D., Chen, Y., Yin, Z., Liao, S., You, B., Lu, D., Sun, Y., Wu, L., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109997 · Cited by 7
“37 The present findings revealed a protein interaction between FN3K and VEGFR2 and FN3K influenced the molecular weight alteration of VEGFR2.”
Snipstad, S., Einen, C., Kastellet, A. B., Fernandez, J. L., Mühlenpfordt, M., Kurbatskaya, A., Årseth, C., Berg, S., Bjørkøy, A., & Davies, C. D. L. (2024) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2024.09.003 · Cited by 6
Wegierak, D., Fishbein, G. S., Abenojar, E., Leon, A. C. D., Zhu, J., Wang, Y., Ferworn, C., Exner, A. A., & Kolios, M. C. (2022) · Journal of Biomedical Optics · doi:10.1117/1.jbo.27.1.016501 · Cited by 5
Desai, F., Jitendra, N., & Singh, L. S. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.18.8293 · Cited by 6
“This is due to tumour neo-vasculature differs significantly from normal vascular development, a process that is not well understood but may be due to different VEGF-A isoforms expressions ( Nagy et al., 2009).”
Sadeghipour, N., Davis, S. C., & Tichauer, K. M. (2018) · Journal of Biomedical Optics · doi:10.1117/1.jbo.23.6.066004 · Cited by 6
“(8) and (9) and assuming Cf;C ≫ vpCp;C from Eq.”
BackgroundAC/DC magnetic device for safe medical use of potentially harmful magnetic nanocarriers
Mustapić, M., Glumac, Z., Heffer, M., Zjalić, M., Prološčić, I., Masud, M. K., Blažetić, S., Vuković, A., Billah, M., Khan, A., et al. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124918 · Cited by 7
Quantification of microvasculature parameters based on optoacoustic angiography data
Perekatova, V., Kirillin, M., Subochev, P., Kurnikov, A. A., Khilov, A. V., Orlova, A., Yuzhakova, D. V., & Turchin, I. V. (2021) · Laser Physics Letters · doi:10.1088/1612-202x/abe2b3 · Cited by 6
“As compared to normal tissue such features as small-sized immature vessels, their high density, tortuosity, branching and chaotic location are typical for the vascular system of most of solid tumors [42].”
BackgroundInmunología del cáncer II: bases moleculares y celulares de la carcinogénesis
Universidad de San Martín de Porres, F. D. M. H., de León, J., Cruz, A. P., & Universidad de San Martín de Porres, F. D. M. H. (2019) · Horizonte Médico (Lima) · doi:10.24265/horizmed.2019.v19n2.11 · Cited by 17
“89 esta nueva vasculatura es frágil, desordenada y con una expresión de moléculas alterada en el endotelio vascular, en comparación con los tejidos normales (62).”
BackgroundMedulloblastoma: novel insights into emerging therapeutic targets
Shaik, S., Maegawa, S., & Gopalakrishnan, V. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1982896 · Cited by 8
Dey, M., Kim, M. H., Nagamine, M., Dogan, M., Kozhaya, L., Unutmaz, D., & Ozbolat, I. T. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.15.484485 · Cited by 6
Li, Y., Feng, Q., Gao, Q., Wang, Y., Zhao, S., Zhang, X., & Zhao, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117264 · Cited by 8
Fundamentals behind the success of nanotechnology in cancer treatment and diagnosis
Chowdhury, M. M. H., Kubra, K., & Islam, A. (2024) · OpenNano · doi:10.1016/j.onano.2024.100215 · Cited by 6
Jiménez-Flores, E., Reytor-González, C., Gavilanes, D. J., Carrillo, C., Horowitz, R., Carrera, J. C. C., Ordóñez, G. D. B., & Simancas‐Racines, D. (2026) · Pharmaceuticals · doi:10.3390/ph19040550 · Cited by 6
Dynamic equilibrium of cellular plasticity: The origin of diseases
Kwan, E., Flowers, J., & Ming, X. (2023) · Frontiers in Ecology and Evolution · doi:10.3389/fevo.2023.1077902 · Cited by 5
“Architectural integrity of the blood vessels exhibit a disorderly, porous, and tortuous quality (Nagy et al., 2009).”
BackgroundInteraction between Gut Microbiota and Dendritic Cells in Colorectal Cancer
Zaher, K. A., & Basingab, F. S. (2023) · Biomedicines · doi:10.3390/biomedicines11123196 · Cited by 6
“Hereditary mutations with spontaneous APC and DNA divergence repair metamorphoses have illuminated the genetic path from premalignant polyps to cancer [70].”
BackgroundA New Retest-Stable Tortuosity Metric for Retinal Vessel Analyses
Giesser, S. D., Turgut, F., Saad, A., Sommer, C., Zhou, Y., Wagner, S. K., Keane, P. A., Becker, M. D., DeBuc, D. C., & Somfai, G. M. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.12.30 · Cited by 5
“6 Within oculomics, blood vessel tortuosity has already been proven to be associated with retinal vein occlusion, aging, diabetes, and hypertension.”
BackgroundVairin, R., Tamminga, C., Shi, Z., Borchardt, C., Jambulapati, J., Bai, R., Wanniarachchi, H. I., Bueno, L. M. A., Hamel, E., Mason, R. P., et al. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117981 · Cited by 5
Obesity Alters the Vascular Morphology and VEGF‐A Signaling in Adipose Tissue
Lee, Y., Tukei, K. L., Fang, Y., Kuila, S., Liu, X., & Imoukhuede, P. I. (2025) · FASEB BioAdvances · doi:10.1096/fba.2025-00027 · Cited by 9
Dietrich, A., Stewart, J., Hüther, M., Helm, M., Schuetze, C., Schnittler, H., Jaffray, D. A., & Kunz‐Schughart, L. A. (2013) · Molecular Imaging and Biology · doi:10.1007/s11307-013-0641-z · Cited by 5
“These are hypothesized to reflect so-called mother vessels—less mature vessels with thin walls and low pericyte coverage [3, 28, 29].”
BackgroundInfluentialHuman intravital microscopy in the study of sarcomas: an early trial of feasibility
Gabriel, E. M., Sukniam, K., Popp, K., & Bagaria, S. P. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1151255 · Cited by 5
Tisza, A., Klikovits, T., Benej, M., Török, S., Szeitz, B., Valkó, Z., Hoda, M. A., Hegedűs, B., Bonta, M., Nischkauer, W., et al. (2023) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15813 · Cited by 4
“38 This may contribute to a hostile microenvironment and to the selection of more aggressive tumour cells.”
Integrating Nanorobotics with Biophysics for Cancer Treatment
Malviya, R., Yadav, D., Sundram, S., Kadry, S., & VIRK, G. S. (2024) · Institute of Physics eBooks · doi:10.1088/978-0-7503-6019-7 · Cited by 4
Spontaneous Tumor Regression and Reversion: Insights and Associations with Reduced Dietary Phosphate
Brown, R. B. (2024) · Cancers · doi:10.3390/cancers16112126 · Cited by 7
“Cancer cells appear to be more vulnerable to nutrient deprivation than normal cells [47], plausibly related to a weaker blood supply to cancer cells due to the highly abnormal structure and function of the tumor vasculature [48].”
BackgroundFernando, W., MacLean, E., Monro, S. M. A., Coombs, M. R. P., Marcato, P., Rupasinghe, H. P. V., & Hoskin, D. W. (2024) · Biomolecules · doi:10.3390/biom14070769 · Cited by 5
“…regulate the increased interstitial pressure in the tumor interior are not clearly delineated, current knowledge suggests that VEGF-induced formation of large numbers of leaky blood vessels with an irregular shape, as well as fibroblast-mediated tumor contractility, play a significant role [11,12].”
BackgroundAn Insight into Perfusion Anisotropy within Solid Murine Lung Cancer Tumors
Martino, A., Terracciano, R., Miličević, B., Milošević, M., Simić, V., Fallon, B. C., Carcamo-Bahena, Y., Royal, A. L. R., Carcamo-Bahena, A. A., Butler, E. B., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081009 · Cited by 6
“Early increases in vasculature density may be attributable to tumor angiogenesis [59], while later decreases may be attributable to necrosis [60].”
BackgroundKroenig, J., Görg, C., Prosch, H., Schumann, L. V., Westhoff, C. C., Alhyari, A., Koenig, F. R. M., Findeisen, H., & Zadeh, E. S. (2024) · Cancers · doi:10.3390/cancers16193365 · Cited by 5
“This limitation of CEUS in evaluating lung lesions must always be taken into account.”
BackgroundHawley, J. J., Allen, S., Thompson, D. M., Schwarz, A. J., & Tranquart, F. (2025) · Investigative Radiology · doi:10.1097/rli.0000000000001197 · Cited by 6
Simulating Therapeutics Using Multiscale Models of the VEGF Receptor System in Cancer
Gabhann, F. M., Stefanini, M. O., & Popel, A. S. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0052-3_2 · Cited by 6
Xu, W., Qian, J., Zhang, Y., Suo, A., Cui, N., Wang, J., Yao, Y., & Wang, H. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb00511j · Cited by 5
An imaging-based computational model for simulating angiogenesis and tumour oxygenation dynamics
Adhikarla, V., & Jeraj, R. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/10/3885 · Cited by 6
“This abnormal vasculature leads to erratic and reduced blood flow with tumour growth (Nagy et al 2009).”
BackgroundCustomizable biomaterials as tools for advanced anti-angiogenic drug discovery
Nguyen, E. H., & Murphy, W. L. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.041 · Cited by 5
“20 Several challenges bar the generation of vascular features that are unique to cancer vasculature: abnormally large, tortuous and leaky blood vessels such as mother vessels and vascular malformations; disorganized, hyperpermable and hyperproliferative vessels such as glomeruloid microvascular proliferations; translu…”
InfluentialDevelopment and repair of blood vessels in the zebrafish spinal cord
Ribeiro, A., da Costa, M. R., de Sena-Tomás, C., Rodrigues, E. C., Quitéria, R., Maçarico, T., Santos, S. C. R., & Saúde, L. (2023) · Open Biology · doi:10.1098/rsob.230103 · Cited by 6
Бакарев, М. А., Levin, V. P., Викторович, К. И., Abdullaev, N. A., & Неймарк, А. И. (2018) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-018-4241-4 · Cited by 5
Quantitative mass spectrometry‐based proteomics in angiogenesis
Hernandez-Fernaud, J. R., Reid, S. E., Neilson, L. J., & Zanivan, S. R. (2013) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200055 · Cited by 5
Steinberger, K. J., Forget, M. A., Bobko, A. A., Mihalik, N. E., Gencheva, M., Roda, J. M., Cole, S. L., Mo, X. M., Hoblitzell, E. H., Evans, R., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2001134 · Cited by 5
Characterization of Sublingual Microvascular Tortuosity in Steady-State Physiology and Septic Shock
Chalkias, A. F., Papagiannakis, N., Katsifa, K., Destounis, A., Gravos, A., Kanakaki, S., Karapiperis, G., Koufaki, F., Prekates, A. A., & Tselioti, P. (2025) · Biomedicines · doi:10.3390/biomedicines13030691 · Cited by 5
“…result from physiological and pathological phenomena associated with microvascular adaptation including increased cytokine and growth factor signaling, changes in flow dynamics, changes in extracellular matrix composition, decreased mural cell coverage, and in response to endurance training [5–7].”
Small arteriole sign: an imaging feature for staging T4a colon cancer
Guan, Z., Li, Z., Ding, Y., Yu, T., Jiang, H., Zhang, X., Yan, S., Hou, W., & Sun, Y. (2023) · European Radiology · doi:10.1007/s00330-023-09968-4 · Cited by 4
“Theoretically, the abundant arterioles feeding tumors always show the properties of faster growth and deeper invasion and are most prone to serosa invasion [23].”
Babich, Y. F., Nuzhdina, M. A., & Syniuta, S. (2017) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-017-1668-0 · Cited by 4
“Moreover, tumor neo-vessels are tortuous and lack the normal hierarchical arrangement of arterioles, capillaries, and venules [25], and they are about one order of magnitude leakier than normal vessels [7].”
BackgroundGreyscale and contrast enhanced ultrasonography for characterization of gastric malignant tumors
Neciu, C. V., Puia, I. C., Badea, A. F., SOCACIU, M. A., Botan, E. C., Chiorean, I., Opincariu, I., Iancu, C., & Badea, R. I. (2017) · Medical Ultrasonography · doi:10.11152/mu-1313 · Cited by 4
“Being highly sensitive in detecting pathological alterations of the microcirculation [28-30], it allows not only to identify the tumoral tissue compared to normal gastric wall but also to differentiate between adenocarcinoma, lymphoma, and GIST.”
BackgroundRole of transthoracic ultrasound in differentiation of the causes of pleural thickening
Kamel, K. M., & Hinnawy, Y. H. E. (2018) · Egyptian Journal of Bronchology · doi:10.4103/ejb.ejb_109_17 · Cited by 4
Swamy, K. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110618 · Cited by 5
Dastidar, D. G., Ghosh, D., Ghosh, S., & Chakrabarti, G. (2021) · Springer eBooks · doi:10.1007/978-981-33-6827-9_38 · Cited by 5
Mares, A. G., Feiner‐Gracia, N., Muela, Y., Martínez, G., Delgado, L., Albertazzi, L., & Pujals, S. (2021) · Applied Nano · doi:10.3390/applnano2040021 · Cited by 4
“Using photolithography we prepared a serpentine microfluidic chip that aims to represent abnormal blood vessel in its tortuous geometry [37,38].”
MethodInfluentialModeling the Effect of Hyperoxia on the Spin–Lattice Relaxation Rate R1 of Tissues
Bluemke, E., Stride, E., & Bulte, D. P. (2022) · Magnetic Resonance in Medicine · doi:10.1002/mrm.29315 · Cited by 4
Wu, J. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111802 · Cited by 7
A collagen-binding SIRPαFc fusion protein for targeted cancer immunotherapy
Liu, J., Xu, T., Pan, D., Fan, J., Fu, Y., Huang, X., Zhao, W., Dong, X., Zhang, S., Kuerban, K., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110951 · Cited by 4
Stress-based navigation for microscopic robots in viscous fluids
Hogg, T. (2018) · Journal of Micro-Bio Robotics · doi:10.1007/s12213-018-0109-y · Cited by 5
“For example, the structure of capillaries and their fluid stresses differ among organs [2], and between tumors and healthy tissue [25,37].”
BackgroundKazachkina, N. I., Lymar, J., Shcheslavskiy, V. I., & Savitsky, A. P. (2021) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545821420013 · Cited by 4
Nanoformulations for Cancer Therapy
Sahoo, A. K., Verma, A., & Pant, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-70299-5_7 · Cited by 4
Kazakov, S. V. (2017) · InTech eBooks · doi:10.5772/intechopen.70056 · Cited by 4
Lampejo, A. O., Lightsey, S. E., Gomes, M. C., Nguyen, C. M., Siemann, D. W., Sharma, B., & Murfee, W. L. (2024) · Annals of Biomedical Engineering · doi:10.1007/s10439-024-03535-8 · Cited by 5
“There is also evidence that formation of early tumor vessels can occur within just hours of direct contact with tumor cells, supporting the early time points used in this study [8].”
Juang, J., Chen, C.-L., Kao, C.-W., Chen, C.-Y., Shen, C.-R., Wang, J.-J., Tsai, Z., & Chu, I. (2023) · Polymers · doi:10.3390/polym15122584 · Cited by 3
“As with other tumors, MIN6 cell line can induce their neovasculature by secreting angiogenic factors [31].”
BackgroundCharacterizing Normal and Tumour Blood Microcirculatory Systems Using Optical Coherence Tomography
Contreras-Sánchez, H. A., Zabel, W. J., Flueraru, C., Lilge, L. D., Taylor, E., & Vitkin, I. A. (2024) · Photonics · doi:10.3390/photonics11090891 · Cited by 6
Insulin Like Growth Factor (IGF)
Salajegheh, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-28140-7_25 · Cited by 3
Self-assembly, buckling and density-invariant growth of three-dimensional vascular networks
Kirkegaard, J. B., Nielsen, B. F., Trusina, A., & Sneppen, K. (2019) · Journal of The Royal Society Interface · doi:10.1098/rsif.2019.0517 · Cited by 3
“The abnormality of tumour vessels is thought to be, in part, due to over-expression of VEGF-A [37].”
BackgroundMicrofluidic Devices for Angiogenesis
Vickerman, V., Kim, C., & Kamm, R. D. (2012) · Studies in mechanobiology, tissue engineering and biomaterials · doi:10.1007/978-3-642-30856-7_5 · Cited by 3
Wang, C. X., Elganainy, D., Zaid, M., Butner, J. D., Agrawal, A., Nizzero, S., Minsky, B. D., Holliday, E. B., Taniguchi, C. M., Smith, G. L., et al. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.04.044 · Cited by 3
Feng, H., Zhou, K., Yuan, Q., Liu, Z., Zhang, T., Chen, H., Xu, B. Y., Sun, Z., Han, Z., Liu, H., et al. (2024) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000802 · Cited by 2
“VEGF, produced by tumor cells and the surrounding stromal tissue, stimulates endothelial cell proliferation and survival and enhances vascular permeability, thus promoting neo-vascularization and exacerbating tumor growth and metastasis (14 – 17).”
Grimaudo, M. S., D’Orazio, F., Renne, S. L., D’Incalci, M., Maki, R. G., Colombo, P., Balzarini, L., Laffi, A., Santoro, A., & Bertuzzi, A. F. (2025) · Cancers · doi:10.3390/cancers17060976 · Cited by 2
“It is well recognized that tumor vessels present altered structure and modified distribution compared with normal tissue [21], being vascularization is a crucial factor for tumor growth [22].”
Ma, Z., Shi, H., Yin, M., Zhang, K., Zhong, W., Liu, Y., Luo, L., Liang, H., & Zhao, Y. (2025) · Angewandte Chemie · doi:10.1002/ange.202507665 · Cited by 2
MRI for Lung Cancer Management: Any Closer to Clinical Application?
Biederer, J., Bergmann, L. L., Ackman, J. B., Hochhegger, B., Azour, L., Triphan, S. M. F., Dinkel, J., Ohno, Y., Ozawa, Y., van Beek, E. J. R., et al. (2026) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.70308 · Cited by 2
“These permit distinction of benign vascularity from malignant vascularity, the latter of which is accompanied by features including spatial heterogeneity and chaotic structure, high permeability to macromolecules, and heterogeneity of vascular density [69].”
Zhang, B., Guo, S., Tang, L., Chen, Y., Glandorf, L., Jessen, E., Chang, X., Jin, T., Reiss, M., Lyu, S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71746-9 · Cited by 3
Degradation of endothelial network in disordered tumor-containing cell sheet
Li, M., & Kino‐oka, M. (2017) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2017.01.017 · Cited by 2
Research progress on the biomedical application of microalgae
Ren, C., Zhong, D., & Zhou, M. (2021) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2021-0117 · Cited by 2
“[25] NAGY J A, CHANG S H, DVORAK A M, et al.”
BackgroundHistopathological Investigation of Dura-like Membrane in Vestibular Schwannomas
Oishi, Y., Tamura, R., Yoshida, K., & Toda, M. (2021) · Brain Sciences · doi:10.3390/brainsci11121649 · Cited by 2
“Unlike normal blood vessels, tumor blood vessels are dilated and irregularly shaped [17].”
BackgroundSOD3 Expression in Tumor Stroma Provides the Tumor Vessel Maturity in Oral Squamous Cell Carcinoma
Oo, M. W., Kawai, H., Eain, H. S., Soe, Y., Takabatake, K., Sanou, S., Shan, Q., Inada, Y., Fujii, M., Fukuhara, Y., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10112729 · Cited by 2
Xu, Q., Huang, S., & Yang, K. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-069047 · Cited by 3
Ravichandran, A., Monkman, J. H., Mehdi, A. M., Blick, T., Snell, C. E., Kulasinghe, A., & Bray, L. J. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166985 · Cited by 2
Monte Carlo simulation of spatial frequency domain imaging for breast tumors during compression
Robbins, C. M., Qian, K., Zhang, Y. J., & Kainerstorfer, J. M. (2024) · Journal of Biomedical Optics · doi:10.1117/1.jbo.29.9.096001 · Cited by 2
“Differential hemodynamic responses likely arise from mechanical differences; 5,41,58 increased metabolic activity within the tumor; 4,59 abnormalities in the vascular network, including disorganized and tortuous blood vessels; 60,61 and increased interstitial fluid pressure within the tumor.”
BackgroundMulticellular model of neuroblastoma proposes unconventional therapy based on multiple roles of p53
Wertheim, K. Y., Chisholm, R., Richmond, P., & Walker, D. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012648 · Cited by 6
The Role of the VEGF Signaling Pathway in Tumor Angiogenesis
Ferrara, N. (2019) · Springer eBooks · doi:10.1007/978-3-319-31215-6_3-1 · Cited by 4
Budhy, S. T. I., Istiati, Sumaryono, B., Arundia, I., & Khrisnanthi, R. S. (2018) · Universitas Airlangga Repository (Universitas Airlangga) · Cited by 2
Vinnakota, M., Bellur, K., Starnes, S. L., & Schulz, M. J. (2023) · Micromachines · doi:10.3390/mi14071338 · Cited by 2
Levy, T., Voeltzke, K., Hauffe, L., Alasad, K., Snaebjörnsson, M., Marciano, R., Scharov, K., Planque, M., Vriens, K., Christen, S., et al. (2022) · bioRxiv · doi:10.1101/2022.09.09.507243 · Cited by 1
“Cancer cells growing within solid tumors experience glucose deprivation due to high glucose consumption combined with defects in tumor vasculature (Nagy et al., 2009; Sullivan et al., 2019).”
Morris, M., Durie, E., Sinnett, V., Toulemonde, M. E. G., Roxanis, I., Allen, S. L., Downey, K., Scudder, J., Gagliardi, T. J., Scott-Mackie, P. L., et al. (2024) · medRxiv · doi:10.1101/2024.10.15.24315514 · Cited by 2
“Tumours have larger microvessel diameters than healthy tissue (Nagy 2009, Forster 2017).”
BackgroundLee, Y., Tukei, K. L., Fang, Y., Kuila, S., Liu, X., & Imoukhuede, P. I. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.23.630107 · Cited by 2
Contrast-enhanced ultrasound of the liver: basics and interpretation of common focal lesions
Zadeh, E. S., Prosch, H., Ba‐Ssalamah, A., Findeisen, H., Alhyari, A., Raab, N., & Görg, C. (2024) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/a-2219-4726 · Cited by 1
“The vascularization pattern of lesions with neoangio-genesis is characterized by a secondary chaotic vascular pattern often of small vessels [12].”
Tun, H. T., Fujisawa, M., Ohara, T., Nishimura, S., Kunitomo, T., Noma, K., & Matsukawa, A. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-17747-2 · Cited by 1
“18 Endothelial cell survival depends mainly on VEGF stimulation when vessels are not covered by pericytes.”
Sabeti, S., Parvar, T. A., Metanat, P., Larson, N. B., Fazzio, R. T., Fatemi, M., & Alizad, A. (2025) · The Breast · doi:10.1016/j.breast.2025.104614 · Cited by 1
“Notably, the blood vessels in malignant tumors exhibit significant heterogeneity and differ markedly from those in normal tissues or benign tumors [15].”
Chen, S., Li, N., Zeng, B., Guo, Y., Zhang, G., Sun, C., Zhang, B., Chen, Q., Li, N., Zhu, C., et al. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03978-6 · Cited by 1
“Angiogenesis plays a critical role in sustaining continuous tumor expansion, and it is associated with increased invasiveness, higher vascular density, tumor metastasis, and tumor recurrence, resulting in poor prognosis [37, 38].”
Assessment of the angiogenic potential of xenografted tumors by biomedical imaging techniques
Николаевна, Д. И., Orlova, A., Subochev, P., Kurnikov, A. A., Glyavina, A., Isakova, A. A., Kukovyakina, E. V., Plotnikova, E. A., Gasparian, M. E., Komarova, A. D., et al. (2025) · Biomedical Optics Express · doi:10.1364/boe.577775 · Cited by 1
“This type of disorganized vasculature is a hallmark of most solid tumors [22].”
Boland, P. A., MacAonghusa, P., Singaravelu, A., McEntee, P. D., Cucek, J., Erzen, S., Aigner, F., Arezzo, A., Burke, J. P., Hompes, R., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-35233-x · Cited by 1
Ravichandran, A., Upton, K. R., Taheri, S., Liu, C., Ferguson, K., Adams, M. N., & Bray, L. J. (2026) · Clinical & Experimental Metastasis · doi:10.1007/s10585-026-10391-4 · Cited by 1
“Tumour vasculature has been shown to have an abnormal phenotype that is reflected in its morphology, barrier capabilities and permeability [9–11].”
Predicting Stereotactic Body Radiation Therapy Response Using an AI-Based Tumor Vessel Biomarker
Park, J. H., Lim, J. H., KIM, S., Kim, C.-H., You, S., Choi, J.-S., Chang, J. W., Park, D. H.-B., Lee, M.-W., Kim, S., et al. (2026) · Technology in Cancer Research & Treatment · doi:10.1177/15330338261428377 · Cited by 2
“1 Although vessel density 2 is the most commonly used parameter to quantify vascular abnormalities, tumor vessels are often more abundant at the tumor – host interface than in the central tumor regions and vessel density tend to decrease as the tumor grows.”
Li, M., Han, F., Ling, S., Su, X., Zhao, Y., Lv, S., & Zhang, X. (2026) · Immunity Inflammation and Disease · doi:10.1002/iid3.70408 · Cited by 2
Impact of heme on the therapeutic efficacy of anti-CD20 antibodies
Jarossay, A., Tavares, A., Lacombe, R. V., Delcourt, H., Lecerf, M., Cruz-Aguirre, A. S., Lassouani, T. H., Gilardin, L., Tareste, D. C., Kaveri, S. V., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111485 · Cited by 1
Metadata
- Authors
- Nagy, J. A., Chang, S.-H., Dvorak, A. M., & Dvorak, H. F.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Dvorak, H F
- ORCID
- Nagy, J A
- Venue
- British Journal of Cancer
- Published
- 2009-02-24
- Volume
- 100
- Issue
- 6
- Pages
- 865-869
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC2661770
- OpenAlex
- W2063556542
- Cited by
- 611
- References
- 38
- Citations by year
- 2026: 30 · 2025: 39 · 2024: 62 · 2023: 47 · 2022: 50 · 2021: 53 · 2020: 61 · 2019: 47 · 2018: 51 · 2017: 48 · 2016: 22 · 2015: 16 · 2014: 12 · 2013: 18 · 2012: 20
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (unspecified)
- Locations
- British Journal of Cancer (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Foundation for Cancer Research
- National Heart, Lung, and Blood Institute (R01HL064402, HL-64402)
- National Cancer Institute (P01 CA 92644, P01CA092644)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor vasculature, VEGF-A, anti-VEGF therapy, tumor angiogenesis, anti-angiogenic therapy resistance
- MeSH terms
- Animals, Blood Vessels, Capillaries, Humans, Neoplasms, Neovascularization, Pathologic, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.